Search research articles
Contact Us
Filters
Showing results (301-310 of 387) with videos related to
Page
of 39
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 2, 2024
[A Case of Response to Pembrolizmab in Unresectable MSI-High Transverse Colon Cancer]
Miki Shindo, Yoshinori Kagawa, Yujiro Nishizawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 2, 2024
[A Case of Pathological Complete Response for MSI-High Locally Advanced Unresectable Transverse Colon Cancer Treated with Nivolumab plus Ipilimumab Combination Therapy]
Yujiro Nishizawa, Yoshinori Kagawa, Akira Inoue, et al.
International Journal of Molecular Sciences
|
May 4, 2026
miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer
Hiroyuki Yamamoto, Yuhki Yokoyama, Shihori Kouda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 22, 2012
A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer
Manabu Soda, Kazutoshi Isobe, Akira Inoue, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 21, 2025
[Case Report of a Patient Who Underwent Open Left Hepatic Lobectomy Followed by Robot-Assisted High-Anterior Resection after Preoperative Chemotherapy for Multiple Simultaneous Liver Metastases of Rectal Cancer]
Kento Nakamori, Yoshinori Kagawa, Yuki Ozato, et al.
JTO Clinical and Research Reports
|
April 14, 2025
Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902
Yoko Tsukita, Rei Umezawa, Taku Nakagawa, et al.
Cancers
|
April 14, 2026
Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights
Yuhki Yokoyama, Yoshihiro Morimoto, Hiroyuki Yamamoto, et al.
Journal of Personalized Medicine
|
November 27, 2021
Improved In Vivo Delivery of Small RNA Based on the Calcium Phosphate Method
Xin Wu, Yuhki Yokoyama, Hidekazu Takahashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy
Akira Inoue, Kunihiko Kobayashi, Kazuhiro Usui, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 27, 2020
Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in the Japanese Joint Committee of Lung Cancer Registry Database
Keigo Kobayashi, Kenzo Soejima, Koichi Fukunaga, et al.
Page
of 39
Search research articles
Search
Showing results (301-310 of 387) with videos related to
Sort By:
Page
of 39
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 2, 2024
[A Case of Response to Pembrolizmab in Unresectable MSI-High Transverse Colon Cancer]
Miki Shindo, Yoshinori Kagawa, Yujiro Nishizawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 2, 2024
[A Case of Pathological Complete Response for MSI-High Locally Advanced Unresectable Transverse Colon Cancer Treated with Nivolumab plus Ipilimumab Combination Therapy]
Yujiro Nishizawa, Yoshinori Kagawa, Akira Inoue, et al.
International Journal of Molecular Sciences
|
May 4, 2026
miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer
Hiroyuki Yamamoto, Yuhki Yokoyama, Shihori Kouda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 22, 2012
A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer
Manabu Soda, Kazutoshi Isobe, Akira Inoue, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 21, 2025
[Case Report of a Patient Who Underwent Open Left Hepatic Lobectomy Followed by Robot-Assisted High-Anterior Resection after Preoperative Chemotherapy for Multiple Simultaneous Liver Metastases of Rectal Cancer]
Kento Nakamori, Yoshinori Kagawa, Yuki Ozato, et al.
JTO Clinical and Research Reports
|
April 14, 2025
Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902
Yoko Tsukita, Rei Umezawa, Taku Nakagawa, et al.
Cancers
|
April 14, 2026
Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights
Yuhki Yokoyama, Yoshihiro Morimoto, Hiroyuki Yamamoto, et al.
Journal of Personalized Medicine
|
November 27, 2021
Improved In Vivo Delivery of Small RNA Based on the Calcium Phosphate Method
Xin Wu, Yuhki Yokoyama, Hidekazu Takahashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy
Akira Inoue, Kunihiko Kobayashi, Kazuhiro Usui, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 27, 2020
Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in the Japanese Joint Committee of Lung Cancer Registry Database
Keigo Kobayashi, Kenzo Soejima, Koichi Fukunaga, et al.
Page
of 39